MedDx Regulatory Solutions

MedDx Regulatory Solutions MedDx Regulatory Solutions MedDx Regulatory Solutions
  • Sign In
  • Create Account

  • Bookings
  • My Account
  • Signed in as:

  • filler@godaddy.com


  • Bookings
  • My Account
  • Sign out

  • Home
  • Our Services
    • Regulatory Strategy
    • Pre-submission Support
    • IDE
    • 510(k) Submissions
    • EU IVDR Support
    • EU MDR Support
  • US Regulatory News
    • MDUFA VI Update
  • EU Regulatory News
    • EU IVDR Update
    • EU MDR Update
  • More
    • Home
    • Our Services
      • Regulatory Strategy
      • Pre-submission Support
      • IDE
      • 510(k) Submissions
      • EU IVDR Support
      • EU MDR Support
    • US Regulatory News
      • MDUFA VI Update
    • EU Regulatory News
      • EU IVDR Update
      • EU MDR Update

MedDx Regulatory Solutions

MedDx Regulatory Solutions MedDx Regulatory Solutions MedDx Regulatory Solutions

Signed in as:

filler@godaddy.com

  • Home
  • Our Services
    • Regulatory Strategy
    • Pre-submission Support
    • IDE
    • 510(k) Submissions
    • EU IVDR Support
    • EU MDR Support
  • US Regulatory News
    • MDUFA VI Update
  • EU Regulatory News
    • EU IVDR Update
    • EU MDR Update

Account


  • Bookings
  • My Account
  • Sign out


  • Sign In
  • Bookings
  • My Account

Presubmission Support

A Presubmission (Q-Submission) is an opportunity to present a new device or IVD to the FDA and receive FDA feedback. Q-Submissions are used to request breakthrough designation status. 


It is an important tool for gauging FDA agreement to proposed studies and the regulatory pathway.


A Presubmission may be the first time a company interacts with the FDA and can set the tone for a successful relationship. 


Let us help you with your Presubmission!



 


Copyright © 2026 MedDx Regulatory Solutions LLC - All Rights Reserved.

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept